Literature DB >> 21047545

An investigation into the role of P-glycoprotein in Alzheimer's disease lesion pathogenesis.

Brian Jeynes1, John Provias.   

Abstract

The pathogenesis of Alzheimer's disease (AD) senile plaque (SP) and neurofibrillary tangle (NFT) lesions putatively involves a compromised blood-brain barrier (BBB). P-glycoprotein (P-gp) is a recognized BBB-related efflux transporter protein. In this investigation we determined the density of SP and NFT lesions and capillary densities stained positively for P-glycoprotein (P-gp), and other transport proteins, in AD and control group (CG) brain samples. Our results indicate that there are significant negative correlations (p<.01) between the densities of NFT and SP(40) lesions and P-gp positive capillaries in AD but not CG brain samples. Significant positive correlations (p<.01) were observed between the densities of P-gp positive capillaries and LRP and RAGE positive capillaries in both AD and CG brains. These results also suggest that the levels of capillary P-gp may contribute to AD lesion development and that the role of P-gp is associated with that of LRP and RAGE. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047545     DOI: 10.1016/j.neulet.2010.10.063

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2.

Authors:  Tasha K Ritchie; Hyewon Kwon; William M Atkins
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1.

Authors:  Begum G Akkaya; Joseph K Zolnerciks; Tasha K Ritchie; Bjoern Bauer; Anika M S Hartz; James A Sullivan; Kenneth J Linton
Journal:  Mol Membr Biol       Date:  2015-05-26       Impact factor: 2.857

3.  ABCB1 C3435T polymorphism influences the risk for Alzheimer's disease.

Authors:  Ágnes Fehér; Anna Juhász; Magdolna Pákáski; János Kálmán; Zoltán Janka
Journal:  J Mol Neurosci       Date:  2014-10-02       Impact factor: 3.444

Review 4.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

5.  An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter.

Authors:  Pavitra Kannan; Martin Schain; Warren W Kretzschmar; Lora Weidner; Nicholas Mitsios; Balázs Gulyás; Hans Blom; Michael M Gottesman; Robert B Innis; Matthew D Hall; Jan Mulder
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.

Authors:  Kati-Sisko Vellonen; Jouni Ihalainen; Marie-Christine Boucau; Fabien Gosselet; Théo Picardat; Mikko Gynther; Katja M Kanninen; Anthony R White; Tarja Malm; Jari Koistinaho; Markus M Forsberg; Marika Ruponen
Journal:  Pharm Res       Date:  2017-09-26       Impact factor: 4.200

7.  RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model.

Authors:  Fang Chen; Arijit Ghosh; Mei Hu; Yan Long; Hongbin Sun; Lingyi Kong; Hao Hong; Susu Tang
Journal:  Neurotox Res       Date:  2017-09-04       Impact factor: 3.911

8.  Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer's Disease.

Authors:  Yijun Pan; Kotaro Omori; Izna Ali; Masanori Tachikawa; Tetsuya Terasaki; Kim L R Brouwer; Joseph A Nicolazzo
Journal:  Mol Pharm       Date:  2018-08-22       Impact factor: 4.939

9.  Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET.

Authors:  Viktoria Zoufal; Thomas Wanek; Markus Krohn; Severin Mairinger; Thomas Filip; Michael Sauberer; Johann Stanek; Thomas Pekar; Martin Bauer; Jens Pahnke; Oliver Langer
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-24       Impact factor: 6.200

Review 10.  Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.

Authors:  Jens Pahnke; Oliver Langer; Markus Krohn
Journal:  Neurobiol Dis       Date:  2014-04-16       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.